Clinical Trial 38013

Los Angeles, CA 90017


Study Summary:

A clinical research study to find out if the drug dabrafenib is safe and to determine how dabrafenib is metabolized (broken down in the body) by people who have varying degrees of renal impairment (a condition in which the kidneys are not working as well as they normally should) compared with people who do not have renal impairment.

You will remain at the clinic for 6 consecutive days starting from the day before you take the study drug (Day -1 to Day 5). After all procedures are completed on Day 5, you will be discharged from the study site.


Inclusion Criteria:

Must be Male and/or female subjects 18-75 years of age

Body mass index (BMI) between ≥18.0 and ≤38.0 kg/m2, with body weight ≥110 lbsg and
no more than 300 lbs

An absolute GFR ≥ 90 mL/min

If on diaysis must be stable enough to skip 1 dialysis treatment.


Qualified Participants May Receive:

If you complete the entire study you may be compensated up to $2,200.00 


View Contact Phone Number


Research Site Profile

View Clinic Profile

Study is Available At:

American Institute of Research
1127 Wilshire Blvd Suite 300
Los Angeles, CA 90017
View Clinic Location

 


If you would like to be contacted by the clinical trial representative and live within 50 miles of this clinic, please enter your contact information, then click 'I Am Interested In This Study'